Recommendation

It has been just 10 years since the potential long-term adverse health outcomes of WNV infection became an international public-health concern. The body of evidence on which this committee can base its conclusions is small. Future investigators will be able to conduct more robust studies on the long-term adverse health outcomes of patients who suffer acute infection by WNV, and create a broader foundation for conclusions about the acute illness and its long-term adverse health outcomes. The committee recommends that the Department of Veterans Affairs (VA) periodically review the literature on long-term adverse health outcomes of WNV infection to supplement the conclusions of this committee.

REFERENCES

Abo-Shehada MN, Odeh JS, Abu-Essud M, Abuharfeil N. 1996. Seroprevalence of brucellosis among high risk people in northern Jordan. International Journal of Epidemiology 25(2):450-454.

Air Force Office of the Surgeon General. 2003. AFMS Deployment Health Surveillance Implementation Instructions.

Akritidis N, Pappas G. 2001. Ascites caused by brucellosis: A report of two cases. Scandinavian Journal of Gastroenterology 36(1):110-112.

Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D. 2003. Laboratory-based diagnosis of brucellosis—a review of the literature. Part II: Serological tests for brucellosis. Clinica y Laboratorio 49(11-12):577-589.

al Deeb SM, Yaqub BA, Sharif HS, Phadke JG. 1989. Neurobrucellosis: Clinical characteristics, diagnosis, and outcome. Neurology 39(4):498-501.

al-Harthi SS. 1989. The morbidity and mortality pattern of Brucella endocarditis. International Journal of Cardiology 25(3):321-324.

al-Kaff AS. 1995. Ocular brucellosis. International Ophthalmology Clinics 35(3):139-145.

Alarcon GS, Bocanegra TS, Gotuzzo E, Hinostroza S, Carrillo C, Vasey FB, Germain BF, Espinoza LR. 1981. Reactive arthritis associated with brucellosis: HAL studies. Journal of Rheumatology 8(4):621-625.

Allos BM. 1997. Association between Campylobacter infection and Guillain-Barre syndrome. Journal of Infectious Diseases 176 (2 Suppl):S125-S128.

Allos BM. 2001. Campylobacter jejuni infections: Update on emerging issues and trends. Clinical Infectious Diseases 32(8):1201-1206.

Almuneef M, Memish ZA. 2003. Prevalence of Brucella antibodies after acute brucellosis. Journal of Chemotherapy 15(2):148-151.

Amino R, Menard R, Frischknecht F. 2005. In vivo imaging of malaria parasites—Recent advances and future directions. Current Opinion in Microbiology 8(4):407-414.

Araj GF, Lulu AR, Khateeb MI, Saadah MA, Shakir RA. 1988. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica 96(2):171-176.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement